Elixirgen Therapeutics
MD - BaltimoreBiotechnology
Focus: Elixirgen Therapeutics is a public biotechnology company headquartered in Baltimore, MD, focused on stem cell therapies and cell therapy development.
Profile data last refreshed 22h ago · AI intelligence enriched 2w ago
Funding Stage
PUBLIC
Open Jobs
0
About Elixirgen Therapeutics
AI assessmentNot HiringNo open roles listed right now. Follow Elixirgen Therapeutics to get notified when they start hiring — the background below is worth knowing for when they do.
Why Work Here
Data completeness
1/9 — Limited
Company HealthSolid
Pipeline
Early-stage
3 total
LOE Risk
Protected
No near-term cliffs
Hiring
0 open
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Pipeline & Clinical Trials
EXG34217
Telomere ShorteningClinical Trials (1)
NCT04211714Study to Evaluate of EXG34217 in Patients With Telomere Biology Disorders With Bone Marrow Failure
Phase 1Help build intelligence for Elixirgen Therapeutics
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.